A study of ZVex-Neo for the treatment of Non-small cell lung cancer.

Trial Profile

A study of ZVex-Neo for the treatment of Non-small cell lung cancer.

Planning
Phase of Trial: Phase I

Latest Information Update: 01 Sep 2016

At a glance

  • Drugs ZVex Neo (Primary)
  • Indications Non-small cell lung cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 01 Sep 2016 According to an Immune Design media release, the company plans to initiate this study in 2017.
    • 01 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top